- /
- Supported exchanges
- / US
- / NNNN.NASDAQ
Anbio Biotechnology Class A Ordinary Shares (NNNN NASDAQ) stock market data APIs
Anbio Biotechnology Class A Ordinary Shares Financial Data Overview
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits. It serves over-the-counter, point-of-care testing, and laboratory markets. Anbio Biotechnology was incorporated in 2021 and is based in Frankfurt am Main, Germany.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Anbio Biotechnology Class A Ordinary Shares data using free add-ons & libraries
Get Anbio Biotechnology Class A Ordinary Shares Fundamental Data
Anbio Biotechnology Class A Ordinary Shares Fundamental data includes:
- Net Revenue: 8 647 K
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Anbio Biotechnology Class A Ordinary Shares Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: 2026-07-07
- EPS/Forecast: NaN
Get Anbio Biotechnology Class A Ordinary Shares End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Anbio Biotechnology Class A Ordinary Shares News
New
Uncovering 3 Undiscovered Gems in the US Market
Over the last 7 days, the United States market has remained flat, yet it has risen by 24% over the past year with earnings expected to grow by 17% per annum in the coming years. In this dynamic enviro...
Undiscovered Gems US Market April 2026
The United States market has experienced a flat performance over the last week, yet it has seen an impressive 30% rise over the past year with earnings projected to grow by 16% annually. In this dynam...
Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum
FRANKFURT AM MAIN, Germany, March 17, 2026 (GLOBE NEWSWIRE) -- Anbio Biotechnology (NASDAQ: NNNN) ("Anbio" or the "Company"), a global diagnostic company in in-vitro diagnostic (IVD) technologies, a...
Here Is What You Need To Know Before Investing In Anbio Biotechnology (NNNN)
Anbio Biotechnology (NASDAQ:NNNN) is one of the 13 Best German Stocks to Invest in Now. The company is engaged in the development of medical technology and the provision of in vitro diagnostics produc...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.